MK-1200 clinical trials

A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-1200 in Participants with Advanced Solid Tumors

This study is testing a new medicine called MK-1200 for people with advanced solid tumours. It aims to see how safe the drug is and if it helps shrink tumours. It's an early-stage study, combining two phases to learn about the drug's effects.